This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/27/15 - 12:56:25 PM ET (BATS BZX Real-time Price)
Div Yield: --
IPCI Day's Range
IPCI 52 Week Range
IPCI Business Summary
Intellipharmaceutics International Inc., a pharmaceutical company, engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada.View IPCI key stats
IntelliPharmaCeutics International Inc - IPCI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates IntelliPharmaCeutics International Inc as a
Sell with a ratings score of E+.
Report Snippet: We rate INTELLIPHARMACEUTICS INTL (IPCI) a SELL. This is based on the combination of unfavorable investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.